Home › Alzeca Biosciences' ADx Imaging Technology Shows Positive Results In Early Detection Of Alzheimer's
 

Keywords :   


Alzeca Biosciences' ADx Imaging Technology Shows Positive Results In Early Detection Of Alzheimer's

2016-06-13 07:00:28| drugdiscoveryonline News Articles

Alzeca Biosciences announced successful preliminary preclinical results for ADx, its innovative, proprietary diagnostic imaging technology, designed to enable diagnosis of Alzheimer’s disease a decade or more before the onset of symptoms of cognitive decline

Tags: results technology shows early

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09This weeks lesson: Weaning matters in the cattle market
20.09Construction giant collapses putting 2,400 jobs at risk
20.09KANSAI HELIOS Further Expands as System Supplier in Italy
More »